2021
DOI: 10.2337/dci20-0078
|View full text |Cite
|
Sign up to set email alerts
|

Response to Comment on Hásková et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744–2750

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…The Guardian Connect System (manufactured by Medtronic) is an example of an AI system with this functionality. This system is based on CGM, has an accompanying smartphone application, 144 and was certified by the FDA in 2018. It is characterized by using AI to predict a hypoglycemic attack an hour in advance based on the CGM data and alerts the patient.…”
Section: Conclusion and Perspectivementioning
confidence: 99%
“…The Guardian Connect System (manufactured by Medtronic) is an example of an AI system with this functionality. This system is based on CGM, has an accompanying smartphone application, 144 and was certified by the FDA in 2018. It is characterized by using AI to predict a hypoglycemic attack an hour in advance based on the CGM data and alerts the patient.…”
Section: Conclusion and Perspectivementioning
confidence: 99%
“…For early intervention, in 2018 the FDA approved the autonomous AI system Digital Diagnostics, which was found to have high diagnostic accuracy in recognizing diabetes retinopathy in retinal screening images 1 . In the same year, the FDA approved the Guardian Connect System, which uses AI technology to interpret biomedical data and predict a hypoglycemic attack an hour in advance 2 . Since then, the FDA has also approved AI technologies that assist with optimizing insulin dosing and therapy for patients 3,4 .…”
mentioning
confidence: 99%